Key facts
- Motif Neurotech’s last known valuation is $34.8M (Jan 2024).
- It has raised $21.7M across 1 recorded rounds; the latest was Early Stage VC ($15.3M) in Jan 2024.
- Notable investors include Capital Factory, Texas Medical Center, Dolby Family Ventures, One Mind, Arboretum Ventures — 17 tracked in total.
- Motif Neurotech has filed 1 Form D with the SEC, most recently Jan 2024 ($15.3M sold to 28 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for Motif Neurotech
Funding rounds
1 roundsAbout Motif Neurotech
Operator of a therapeutic brain-computer interface company intended for treatment-resistant depression. The company uses proprietary wireless data and power solutions to miniaturize implants, reduce surgical burden, and provide personalized treatments that restore hope and improve quality of life, enabling patients to repair neural circuits with minimally invasive electronic therapies.
- Sector
- Healthcare
- HQ
- Houston, TX, United States
- Founded
- 2022
- Employees
- 33
- Website
- motifneuro.tech/
- Ownership
- Privately Held (backing)
Motif Neurotech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Motif Neurotech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Motif Neurotech in its N-PORT filings yet. We sweep new filings monthly.